PlainPharmaWatch

CMS Open Payments · Tool

DiaSorin Inc. vs BTG International, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

DiaSorin Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 5,574, versus 2,745 for the other company. Its single largest recorded recipient represents 0.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

DiaSorin Inc.
HHI 5,574 · top recipient 0.7%
Ranked #296 of 1,838 companies by HHI
BTG International, Inc.
HHI 2,745 · top recipient 0.5%
Ranked #607 of 1,838 companies by HHI

Payment Overview

Company A

DiaSorin Inc.

Total Payments
$1.2M
% of Industry
0.0%
Transactions
65
Avg per Transaction
$18.2K
Recipients
37
Avg per Recipient
$32.0K
Payment Types
5
Top Payment Type
Consulting Fee
Total Payments
$1.2M
% of Industry
0.0%
Transactions
766
Avg per Transaction
$1.5K
Recipients
757
Avg per Recipient
$1.6K
Payment Types
7
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

DiaSorin Inc. vs BTG International, Inc. - total reported payments in CMS Open Payments PY2024

DiaSorin Inc.$1.2MBTG International, Inc.$1.2M

Payment Types Breakdown

DiaSorin Inc.

Consulting Fee $302.0K

25.5%

Compensation for Services Other Than Consulting $56.6K

4.8%

Travel and Lodging $6.2K

0.5%

Compensation for Faculty or Speaker (Medical Education) $6.0K

0.5%

Food and Beverage $715.67

0.1%

BTG International, Inc.

Consulting Fee $501.8K

42.4%

Compensation for Services Other Than Consulting $90.2K

7.6%

Travel and Lodging $31.9K

2.7%

Food and Beverage $18.3K

1.6%

Space Rental or Facility Fees $15.1K

1.3%

Grant $12.5K

1.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

DiaSorin Inc.

  1. 1

    DAVID ENGMAN

    $274,973.33 · 5 txns

  2. 2

    Inspira Medical Center Vineland

    $21,847.50 · 5 txns

  3. 3

    Cleveland Clinic Hospital

    $15,860.00 · 1 txns

  4. 4

    DAVID HALE

    $15,633.75 · 12 txns

  5. 5

    St. Lukes Regional Medical Center

    $12,350.00 · 2 txns

BTG International, Inc.

  1. 1

    Denver Health Medical Center

    $336,459.61 · 12 txns

  2. 2

    Charles Pollack

    $76,500.00 · 25 txns

  3. 3

    Lindsey Epperson

    $35,552.06 · 59 txns

  4. 4

    Cleveland Clinic Hospital

    $32,500.00 · 1 txns

  5. 5

    Scott Howard

    $27,188.37 · 40 txns

Summary Comparison

Metric DiaSorin Inc. BTG International, Inc.
Total Payments $1.2M $1.2M
% of Industry Total 0.0% 0.0%
Transaction Count 65 766
Avg per Transaction $18.2K $1.5K
Recipient Count 37 757
Avg per Recipient $32.0K $1.6K
Payment Type Count 5 7
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.